$VREX
Varex Imaging Corp Stock $vrex

$vrex Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000168162220000116 Filed on November 30, 2020

Income Statement

Concept	2020 Q4	2019 Q3	2018 Q3
Revenue	$170.0M	$202.4M	$204.8M
YoY Change		-1.17%	-5.05%
Cost Of Revenue	$122.7M	$130.8M	$145.6M
YoY Change		-10.16%	5.51%
Gross Profit	$47.30M	$71.60M	$59.20M
YoY Change		20.95%	-23.81%
Gross Profit Margin	27.82%	35.38%	28.91%
Selling, General & Admin	$33.30M	$35.80M	$32.10M
YoY Change		11.53%	9.93%
% of Gross Profit	70.4%	50.0%	54.22%
Research & Development	$17.30M	$19.60M	$20.70M
YoY Change		-5.31%	-5.48%
% of Gross Profit	36.58%	27.37%	34.97%
Depreciation & Amortization	$9.100M	$9.100M	$13.70M
YoY Change		-33.58%	29.25%
% of Gross Profit	19.24%	12.71%	23.14%
Operating Expenses	$50.60M	$55.40M	$52.80M
YoY Change		4.92%	3.33%
Operating Profit	-$3.300M	$16.20M	$6.400M
YoY Change		153.13%	-75.94%
Interest Expense	-$14.50M	-$7.700M	-$5.100M
YoY Change		50.98%	-21.54%
% of Operating Profit		-47.53%	-79.69%
Other Income/Expense, Net	-$3.100M	$1.700M	-$1.100M
YoY Change		-254.55%	-42.11%
Pretax Income	-$30.50M	$10.20M	$200.0K
YoY Change		5000.0%	-98.9%
Income Tax	-$4.300M	$2.000M	$900.0K
% Of Pretax Income		19.61%	450.0%
Net Earnings	-$26.40M	$8.100M	$0.00
YoY Change			-100.0%
Net Earnings / Revenue	-15.53%	4.0%	0.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$675.2K	$206.6K	$0.00
COMMON SHARES
Basic Shares Outstanding	39.20M shares	38.40M shares	38.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.6M	$29.90M	$51.90M
YoY Change		-42.39%	-37.7%
Cash & Equivalents	$100.6M	$29.90M	$51.90M
Short-Term Investments
Other Short-Term Assets	$25.70M	$19.30M	$17.10M
YoY Change		12.87%	23.02%
Inventory	$271.9M	$248.2M	$235.1M
Prepaid Expenses
Receivables	$123.8M	$141.0M	$154.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$522.0M	$438.4M	$458.1M
YoY Change		-4.3%	-7.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$172.9M	$142.3M	$144.9M
YoY Change		-1.79%	-2.29%
Goodwill	$293.1M	$290.8M	$243.6M
YoY Change		19.38%	0.7%
Intangibles	$67.50M	$86.30M	$73.80M
YoY Change		16.94%	-19.17%
Long-Term Investments	$2.500M	$2.000M	$51.00M
YoY Change		-96.08%	-2.49%
Other Assets	$32.20M	$27.50M	$34.50M
YoY Change		-20.29%	213.64%
Total Long-Term Assets	$617.5M	$600.5M	$529.8M
YoY Change		13.34%	-2.75%
TOTAL ASSETS
Total Short-Term Assets	$522.0M	$438.4M	$458.1M
Total Long-Term Assets	$617.5M	$600.5M	$529.8M
Total Assets	$1.140B	$1.039B	$987.9M
YoY Change		5.16%	-5.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$72.90M	$58.20M	$66.30M
YoY Change		-12.22%	12.56%
Accrued Expenses	$70.50M	$75.70M	$54.60M
YoY Change		38.64%	-12.5%
Deferred Revenue	$8.600M	$10.50M	$13.50M
YoY Change		-22.22%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.500M	$30.70M	$25.00M
YoY Change		22.8%	25.0%
Total Short-Term Liabilities	$160.6M	$175.1M	$152.0M
YoY Change		15.2%	0.13%
LONG-TERM LIABILITIES
Long-Term Debt	$452.8M	$364.4M	$364.8M
YoY Change		-0.11%	-21.36%
Other Long-Term Liabilities	$34.90M	$32.50M	$29.80M
YoY Change		9.06%	534.04%
Total Long-Term Liabilities	$487.7M	$396.9M	$394.6M
YoY Change		0.58%	-15.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$160.6M	$175.1M	$152.0M
Total Long-Term Liabilities	$487.7M	$396.9M	$394.6M
Total Liabilities	$673.7M	$580.2M	$548.5M
YoY Change		5.78%	-15.6%
SHAREHOLDERS EQUITY
Retained Earnings	$16.10M	$74.40M	$58.90M
YoY Change		26.32%	67.81%
Common Stock	$400.0K	$400.0K	$400.0K
YoY Change		0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$451.7M	$444.9M	$426.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.140B	$1.039B	$987.9M
YoY Change		5.16%	-5.02%

Cashflow Statement

Concept	2020 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$26.40M	$8.100M	$0.00
YoY Change			-100.0%
Depreciation, Depletion And Amortization	$9.100M	$9.100M	$13.70M
YoY Change		-33.58%	29.25%
Cash From Operating Activities	-$11.80M	$22.90M	$18.50M
YoY Change		23.78%	25.0%
INVESTING ACTIVITIES
Capital Expenditures	-$4.000M	-$6.500M	-$5.100M
YoY Change		27.45%	-59.52%
Acquisitions
YoY Change
Other Investing Activities	$300.0K	-$300.0K	-$5.400M
YoY Change		-94.44%	-228.57%
Cash From Investing Activities	-$3.700M	-$6.800M	-$10.50M
YoY Change		-35.24%	25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	26.90M	-14.80M	-8.900M
YoY Change		66.29%	-29.37%
NET CHANGE
Cash From Operating Activities	-11.80M	22.90M	18.50M
Cash From Investing Activities	-3.700M	-6.800M	-10.50M
Cash From Financing Activities	26.90M	-14.80M	-8.900M
Net Change In Cash	11.40M	1.300M	-900.0K
YoY Change		-244.44%	-85.48%
FREE CASH FLOW
Cash From Operating Activities	-$11.80M	$22.90M	$18.50M
Capital Expenditures	-$4.000M	-$6.500M	-$5.100M
Free Cash Flow	-$7.800M	$29.40M	$23.60M
YoY Change		24.58%	-13.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity File Number EntityFileNumber	001-37860
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001681622
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-02
CY2018	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201409Member
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201602Member
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-10-02
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity Registrant Name EntityRegistrantName	VAREX IMAGING CORPORATION
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-3434516
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	1678 S. Pioneer Road
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84104
CY2020	dei	City Area Code CityAreaCode	(801)
CY2020	dei	Local Phone Number LocalPhoneNumber	972-5000
CY2020	dei	Security12b Title Security12bTitle	Common Stock
CY2020	dei	Trading Symbol TradingSymbol	VREX
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020Q2	dei	Entity Public Float EntityPublicFloat	597500000	USD
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39200000	shares
CY2020	us-gaap	Revenues Revenues	738300000	USD
CY2019	us-gaap	Revenues Revenues	780600000	USD
CY2018	us-gaap	Revenues Revenues	773400000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	548100000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	523900000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	519500000	USD
CY2020	us-gaap	Gross Profit GrossProfit	190200000	USD
CY2019	us-gaap	Gross Profit GrossProfit	256700000	USD
CY2018	us-gaap	Gross Profit GrossProfit	253900000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78900000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78100000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	83000000.0	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	142200000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	128100000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	123400000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2800000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3000000.0	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	223900000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	211000000.0	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	209400000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-33700000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	45700000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	44500000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	USD
CY2020	us-gaap	Interest Expense InterestExpense	31400000	USD
CY2019	us-gaap	Interest Expense InterestExpense	21100000	USD
CY2018	us-gaap	Interest Expense InterestExpense	21700000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7600000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3200000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2700000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38900000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24200000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18800000	USD
CY2020	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-72600000	USD
CY2019	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	21500000	USD
CY2018	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	25700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15200000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5700000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2600000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-57400000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	15800000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	28300000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	500000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	800000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-57900000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	15500000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	27500000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.49
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.49
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38800000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38200000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37900000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38800000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38600000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38400000	shares
CY2020	us-gaap	Profit Loss ProfitLoss	-57400000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	15800000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	28300000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	400000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-6200000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	5200000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-600000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1300000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	200000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1500000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2500000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7500000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5000000.0	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-54900000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	8300000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	33300000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	500000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	300000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	800000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-55400000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8000000.0	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32500000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100600000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29900000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	300000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1000000.0	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	123800000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	141000000.0	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	271900000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	248200000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25700000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19300000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	522000000.0	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	438400000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	145200000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142300000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	293100000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	290800000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	67500000	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	86300000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	51300000	USD
CY2019Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	53600000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	500000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27700000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32200000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27500000	USD
CY2020Q4	us-gaap	Assets Assets	1139500000	USD
CY2019Q3	us-gaap	Assets Assets	1038900000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	72900000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	58200000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70500000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	75700000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6100000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2500000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	30700000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8600000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10500000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	160600000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	175100000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	452800000	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	364400000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2300000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8200000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23100000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34900000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32500000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	673700000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	580200000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2019Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	10500000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39059094	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39059094	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38371305	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38371305	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	400000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	400000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	434400000	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	371800000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	800000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1700000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16100000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	74400000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	451700000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	444900000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	14100000	USD
CY2019Q3	us-gaap	Minority Interest MinorityInterest	3300000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	465800000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	448200000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1139500000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1038900000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	379000000.0	USD
CY2018	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	27800000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3800000	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2200000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3300000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000000.0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	5200000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	200000	USD
CY2018	vrex	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	1800000	USD
CY2018	us-gaap	Stockholders Equity Other StockholdersEquityOther	200000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	428300000	USD
CY2019	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	15300000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	800000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2100000	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3800000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11700000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-6200000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1300000	USD
CY2019	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1400000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	448200000	USD
CY2020	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-57900000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1500000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1800000	USD
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3600000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-600000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	49700000	USD
CY2020	vrex	Adjustments To Additional Paid In Capital Purchase Of Bond Hedges AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges	61000000.0	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	49800000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-1500000	USD
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	7400000	USD
CY2020	vrex	Noncontrolling Interest Increase From Reclassification From Mezzanine Equity NoncontrollingInterestIncreaseFromReclassificationFromMezzanineEquity	11300000	USD
CY2020	us-gaap	Stockholders Equity Other StockholdersEquityOther	600000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	465800000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-57400000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	15800000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	28300000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	13400000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	11700000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	10000000.0	USD
CY2019	vrex	Deferred Income Tax Expense Benefit Excluding Portionto Apic DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC	-12900000	USD
CY2020	us-gaap	Depreciation Depreciation	22300000	USD
CY2019	us-gaap	Depreciation Depreciation	23500000	USD
CY2018	us-gaap	Depreciation Depreciation	26000000.0	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17200000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15700000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16200000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2800000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3000000.0	USD
CY2020	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	2700000	USD
CY2019	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
CY2018	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1300000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	18100000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	3100000	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	3100000	USD
CY2020	vrex	Deferred Income Tax Expense Benefit Excluding Portionto Apic DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC	-3100000	USD
CY2018	vrex	Deferred Income Tax Expense Benefit Excluding Portionto Apic DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC	-7700000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5100000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2400000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2300000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-1300000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-2300000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	3900000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4700000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-800000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-700000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-17700000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14800000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9000000.0	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42700000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11100000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2400000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9300000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4300000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2000000.0	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	14300000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9000000.0	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5200000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8100000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10900000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10200000	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2000000.0	USD
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5200000	USD
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2400000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13200000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71900000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	85300000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23500000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19800000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20400000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1600000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	69500000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4800000	USD
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1800000	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3900000	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26900000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93200000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25200000	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	593800000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	85400000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10000000.0	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	483900000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	87000000.0	USD
CY2018	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	106000000.0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	16700000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	500000	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	400000	USD
CY2020	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	49800000	USD
CY2019	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2020	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	61000000.0	USD
CY2019	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2018	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2020	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3600000	USD
CY2019	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3800000	USD
CY2018	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3300000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1500000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	800000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3800000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1800000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2100000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2300000	USD
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2018	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1800000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1700000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-500000	USD
CY2018	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-600000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	83600000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-90400000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	900000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-700000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-500000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	70800000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22100000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30800000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31300000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53400000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84200000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102100000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31300000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53400000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	16700000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	19900000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	19300000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4200000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8200000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13800000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1600000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1800000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2000000.0	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2020	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September 30. Fiscal year 2020 was the 53-week period that ended October 2, 2020, fiscal year 2019 was the 52-week period that ended September 27, 2019, and fiscal year 2018 was the 52-week period ended September 28, 2018.</span></div>
CY2020	vrex	Numberof Variable Interest Entities NumberofVariableInterestEntities	2	entity
CY2020	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, goodwill and intangible assets, warranties, contract liabilities, long-lived asset valuations, impairment on investments, financial instruments, and taxes on earnings. Actual results could differ from these estimates.<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus (“COVID-19”) pandemic and the mitigation efforts by governments to attempt to control its spread created uncertainties and disruptions in the economic and financial markets. The extent to which COVID-19 will continue to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, unemployment rates, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. During the 2020 fiscal year, as a result of the economic downturn resulting from COVID-19, the Company experienced reduced demand in the Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the currently estimated future impacts of COVID-19 as of October 2, 2020 and through the date of filing this report. The accounting matters assessed included, but were not limited to, the Company’s carrying value of goodwill, intangibles, long-lived assets, equity method investments, inventory and related reserves, and allowance for doubtful accounts. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company’s consolidated financial statements in future reporting periods. These future developments are highly uncertain and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the financial statements.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 1 to the Company’s consolidated financial statements for the year ended September 27, 2019, as reissued on September 22, 2020 in our Current Report on Form 8-K, the Company concluded that there was substantial doubt about its ability to continue as a going concern. This assessment was based on the Company’s financial projections, which included the anticipated adverse effects of the COVID-19 pandemic on the Company’s financial condition and results of operations, and which indicated that it was probable that the Company would be in violation of certain leverage ratio covenants contained in its previously existing credit agreement.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described more fully in Note 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on September 30, 2020, the Company issued $300.0 million aggregate principal amount of 7.875% Senior Secured Notes due in 2027, the proceeds from which were used to repay the principal amounts outstanding under the Company’s previously existing credit agreement (which was then terminated), and entered into a new revolving credit agreement consisting of a $100.0 million asset-based loan revolving credit facility. The Senior Secured Notes do not contain any financial covenants and the asset-based loan revolving credit facility’s financial covenant is limited to when excess availability falls below a specified threshold. Management has concluded that the replacement of the Company's previously existing credit agreement with the Senior Secured Notes, combined with our current and anticipated future cash flows, has alleviated the substantial doubt about the Company's ability to continue as a going concern and the Company has sufficient liquidity to satisfy our obligations over the twelve-month period from the issuance date of these consolidated financial statements.</span></div>
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29900000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100600000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51900000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29900000	USD
CY2019Q3	us-gaap	Restricted Cash RestrictedCash	1400000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	1500000	USD
CY2018Q3	us-gaap	Restricted Cash RestrictedCash	1500000	USD
CY2019Q3	us-gaap	Restricted Cash RestrictedCash	1400000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31300000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102100000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53400000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31300000	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Risk Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for doubtful accounts based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier.
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	184600000	USD
CY2019Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	160100000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	23900000	USD
CY2019Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	27900000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	63400000	USD
CY2019Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	60200000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	271900000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	248200000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	356400000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	341900000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	211200000	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	199600000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	145200000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142300000	USD
CY2020	us-gaap	Depreciation Depreciation	22300000	USD
CY2019	us-gaap	Depreciation Depreciation	23500000	USD
CY2018	us-gaap	Depreciation Depreciation	26000000.0	USD
CY2018	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	4200000	USD
CY2020Q3	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	2700000	USD
CY2019	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	reportingUnit
CY2018	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	reportingUnit
CY2020	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	reportingUnit
CY2018	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2019	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2020Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2800000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2800000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3000000.0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8100000	USD
CY2018Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7300000	USD
CY2020	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	15100000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	12900000	USD
CY2020	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	15100000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	12100000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8100000	USD
CY2019Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8100000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	300000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1000000.0	USD
CY2018Q3	vrex	Contract With Customer Asset ContractWithCustomerAsset	24400000	USD
CY2019	vrex	Increase Decrease In Contractwith Customer Asset Costs Recovered From Product Returns IncreaseDecreaseInContractwithCustomerAssetCostsRecoveredFromProductReturns	-6400000	USD
CY2019	vrex	Increase Decrease In Contractwith Customer Asset Shipment Of Product Subject To Return IncreaseDecreaseInContractwithCustomerAssetShipmentOfProductSubjectToReturn	5700000	USD
CY2019Q3	vrex	Contract With Customer Asset ContractWithCustomerAsset	23700000	USD
CY2020	vrex	Increase Decrease In Contractwith Customer Asset Costs Recovered From Product Returns IncreaseDecreaseInContractwithCustomerAssetCostsRecoveredFromProductReturns	-5600000	USD
CY2020	vrex	Increase Decrease In Contractwith Customer Asset Shipment Of Product Subject To Return IncreaseDecreaseInContractwithCustomerAssetShipmentOfProductSubjectToReturn	6500000	USD
CY2019	vrex	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	6300000	USD
CY2020Q4	vrex	Contract With Customer Asset ContractWithCustomerAsset	24600000	USD
CY2018Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	27100000	USD
CY2019	vrex	Contract With Customer Refund Liability Amount Released ContractWithCustomerRefundLiabilityAmountReleased	7000000.0	USD
CY2019Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	26400000	USD
CY2020	vrex	Contract With Customer Refund Liability Amount Released ContractWithCustomerRefundLiabilityAmountReleased	6200000	USD
CY2020	vrex	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	7200000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	27400000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8400000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	10500000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P6Y
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27700000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	500000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6100000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	200000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23100000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	400000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M6D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M18D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.041
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	8400000	USD
CY2020	vrex	Lease Cost Finance Lease Costs LeaseCostFinanceLeaseCosts	300000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	8000000.0	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	300000	USD
CY2020	vrex	Cash Paid For Operating And Finance Leases CashPaidForOperatingAndFinanceLeases	8300000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10600000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6600000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	200000	USD
CY2020	vrex	Finance And Operating Right Of Use Assets Obtained In Exchange For Lease Liabilities FinanceAndOperatingRightOfUseAssetsObtainedInExchangeForLeaseLiabilities	10800000	USD
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5100000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5300000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7100000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	200000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	200000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4200000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	200000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3500000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3300000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	9400000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	34100000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	600000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4900000	USD
CY2020Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	0	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	29200000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	600000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	7500000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5400000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4700000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1800000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	900000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	200000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2500000	USD
CY2019Q3	us-gaap	Equity Method Investments EquityMethodInvestments	2000000.0	USD
CY2020Q3	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	94	employee
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	33000000.0	USD
CY2019Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	32100000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	8100000	USD
CY2019Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	8100000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5600000	USD
CY2019Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	10700000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	7400000	USD
CY2019Q3	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	6900000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	8900000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16400000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9000000.0	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70500000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	75700000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3900000	USD
CY2019Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3900000	USD
CY2020Q4	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	800000	USD
CY2019Q3	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	900000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	6500000	USD
CY2019Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	5500000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	19900000	USD
CY2019Q3	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	19500000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3800000	USD
CY2019Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2700000	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34900000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32500000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2100000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2300000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3900000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-900000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1000000.0	USD
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2700000	USD
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-0.0	USD
CY2018	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3700000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1900000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1200000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7600000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3200000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2700000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-57900000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	15500000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	27500000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38800000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38200000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37900000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	400000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	500000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.49
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38800000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38600000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38400000	shares
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.49
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3500000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1900000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1200000	shares
CY2019Q3	vrex	Longterm Debt Excluding Current Maturities Gross LongtermDebtExcludingCurrentMaturitiesGross	370100000	USD
CY2020	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Loss DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLoss	200000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2500000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	30700000	USD
CY2020	vrex	Proceeds From Repayments Of Long Term Debt Current Maturities ProceedsFromRepaymentsOfLongTermDebtCurrentMaturities	-28200000	USD
CY2020Q4	vrex	Longterm Debt Excluding Current Maturities Gross LongtermDebtExcludingCurrentMaturitiesGross	508800000	USD
CY2020	vrex	Proceeds From Repayments Of Long Term Debt Excluding Current Maturities ProceedsFromRepaymentsOfLongTermDebtExcludingCurrentMaturities	138700000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	50400000	USD
CY2019Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2020	vrex	Increase Decrease In Unamortized Discount IncreaseDecreaseInUnamortizedDiscount	-50400000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-56000000.0	USD
CY2019Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-5700000	USD
CY2020	vrex	Increase Decrease Unamortized Discount Premium And Debt Issuance Costs Net IncreaseDecreaseUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-50300000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	455300000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	395100000	USD
CY2020	vrex	Proceeds From Repayments Of Debt Net Of Issuance Costs ProceedsFromRepaymentsOfDebtNetOfIssuanceCosts	60200000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2500000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2600000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2400000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1500000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	201400000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	300900000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	511300000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2500000	USD
CY2020Q4	vrex	Longterm Debt Excluding Current Maturities Gross LongtermDebtExcludingCurrentMaturitiesGross	508800000	USD
CY2020Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	24.975
CY2020Q2	vrex	Class Of Warrant Or Right Percent Increase Of Strike Price Over Sale Price ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice	0.50
CY2020Q2	vrex	Payment Of Hedge Transactions From Proceeds Of Convertible Debt PaymentOfHedgeTransactionsFromProceedsOfConvertibleDebt	11200000	USD
CY2020Q2	vrex	Payment Of Hedge Transactions From Proceeds Of Warrant Transactions PaymentOfHedgeTransactionsFromProceedsOfWarrantTransactions	49800000	USD
CY2020Q2	us-gaap	Payments For Hedge Financing Activities PaymentsForHedgeFinancingActivities	61000000.0	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	395100000	USD
CY2020Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
CY2019Q3	us-gaap	Goodwill Goodwill	290800000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	2300000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	293100000	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	86300000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17200000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15700000	USD
CY2019Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2800000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	138900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	138900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	71400000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	67500000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	137500000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	54000000.0	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	83500000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	0	USD
CY2019Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2800000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	71400000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	67500000	USD
CY2019Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	140300000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	54000000.0	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16200000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2800000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3000000.0	USD
CY2020Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill Fair Value Disclosure IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure	0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	16500000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	15000000.0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	13900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9300000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3200000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	9600000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	67500000	USD
CY2020Q4	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	2000000.0	USD
CY2019Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	10500000	USD
CY2018Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	11100000	USD
CY2020	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	500000	USD
CY2019	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	500000	USD
CY2020	vrex	Reclassification From Redeemable Noncontrolling Interest To Permanent Equity ReclassificationFromRedeemableNoncontrollingInterestToPermanentEquity	11300000	USD
CY2019	vrex	Reclassification From Redeemable Noncontrolling Interest To Permanent Equity ReclassificationFromRedeemableNoncontrollingInterestToPermanentEquity	0	USD
CY2020	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	500000	USD
CY2019	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	500000	USD
CY2020	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	800000	USD
CY2019	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-600000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	USD
CY2019Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	10500000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13400000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11700000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10000000.0	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2269000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.60
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M6D
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1220300	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	591000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	23.39
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	61000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	30.17
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	64000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	22.93
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2735000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.23
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1794000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	30.48
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M24D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2020Q4	us-gaap	Share Price SharePrice	12.37
CY2020	vrex	Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodGrantDateFairValue	4400000	USD
CY2019	vrex	Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodGrantDateFairValue	3000000.0	USD
CY2018	vrex	Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodGrantDateFairValue	3100000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	587000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1700000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	678000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	33.18
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.30
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	224000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	32.77
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	86000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	31.27
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	955000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	25.54
CY2020	vrex	Sharebased Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Grant Date Fair Value SharebasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue	11900000	USD
CY2019	vrex	Sharebased Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Grant Date Fair Value SharebasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue	9000000.0	USD
CY2018	vrex	Sharebased Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Grant Date Fair Value SharebasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue	10100000	USD
CY2020Q4	vrex	Sharebased Compensationby Sharebased Payment Award Equity Instruments Otherthan Options Shares Outstanding Market Value SharebasedCompensationbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsSharesOutstandingMarketValue	11800000	USD
CY2019Q3	vrex	Sharebased Compensationby Sharebased Payment Award Equity Instruments Otherthan Options Shares Outstanding Market Value SharebasedCompensationbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsSharesOutstandingMarketValue	19200000	USD
CY2018Q3	vrex	Sharebased Compensationby Sharebased Payment Award Equity Instruments Otherthan Options Shares Outstanding Market Value SharebasedCompensationbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsSharesOutstandingMarketValue	18400000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-16300000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9200000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-2100000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1400000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1300000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-300000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	5700000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	6800000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7500000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-12000000.0	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17300000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5100000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1700000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10000000.0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7000000.0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	600000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1600000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	700000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2100000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1400000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3200000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11600000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7700000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.042
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15200000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5700000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2600000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-74100000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5900000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3700000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1500000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	15600000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	22000000.0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-72600000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21500000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25700000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.245
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.009
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.418
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.019
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.130
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.008
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.037
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.102
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.111
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.047
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.019
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.004
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.060
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.008
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.110
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.112
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.019
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent	-0.047
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent	0
CY2020	vrex	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackPercent	0.056
CY2019	vrex	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackPercent	0
CY2018	vrex	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.006
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.025
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1100000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27000000.0	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24300000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.209
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.265
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.101
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4400000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	5600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4200000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3100000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	1700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	1600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1300000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	1000000.0	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	1000000.0	USD
CY2019Q3	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0	USD
CY2020Q4	vrex	Deferred Tax Asset Lease Liabilities DeferredTaxAssetLeaseLiabilities	7200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	5900000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	1900000	USD
CY2020Q4	vrex	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Financing Fees DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredFinancingFees	3300000	USD
CY2019Q3	vrex	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Financing Fees DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredFinancingFees	0	USD
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4700000	USD
CY2019Q3	vrex	Deferred Tax Asset Lease Liabilities DeferredTaxAssetLeaseLiabilities	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6000000.0	USD
CY2019Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	66700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	46100000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	38000000.0	USD
CY2019Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27300000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	16600000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	19300000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	12400000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	10600000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	2800000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	3300000	USD
CY2020Q4	vrex	Deferred Tax Liabilities Lease Right Of Use Assets DeferredTaxLiabilitiesLeaseRightOfUseAssets	6700000	USD
CY2019Q3	vrex	Deferred Tax Liabilities Lease Right Of Use Assets DeferredTaxLiabilitiesLeaseRightOfUseAssets	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1300000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2300000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	39800000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	35500000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1800000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	38000000.0	USD
CY2019Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27300000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	39800000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	35500000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1800000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4300000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8200000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	100000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27000000.0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	4300000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	22700000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9900000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	14800000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18800000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4000000.0	USD
CY2020	vrex	Valuation Allowance Deferred Tax Asset Increase From Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount	0	USD
CY2019	vrex	Valuation Allowance Deferred Tax Asset Increase From Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount	12000000.0	USD
CY2018	vrex	Valuation Allowance Deferred Tax Asset Increase From Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount	0	USD
CY2020	vrex	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	10200000	USD
CY2019	vrex	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	2800000	USD
CY2018	vrex	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	2200000	USD
CY2020	vrex	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	300000	USD
CY2019	vrex	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	0	USD
CY2018	vrex	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	2500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18800000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4000000.0	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	4200000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	8200000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	200000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	200000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	200000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2020	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	100000	USD
CY2019	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	100000	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2020	us-gaap	Revenues Revenues	738300000	USD
CY2019	us-gaap	Revenues Revenues	780600000	USD
CY2018	us-gaap	Revenues Revenues	773400000	USD
CY2020	us-gaap	Gross Profit GrossProfit	190200000	USD
CY2019	us-gaap	Gross Profit GrossProfit	256700000	USD
CY2018	us-gaap	Gross Profit GrossProfit	253900000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	223900000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2600000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-57400000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	211000000.0	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	209400000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38900000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24200000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18800000	USD
CY2020	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-72600000	USD
CY2019	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	21500000	USD
CY2018	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	25700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15200000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5700000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	15800000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	28300000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	500000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	800000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-57900000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	15500000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	27500000	USD
CY2020	us-gaap	Revenues Revenues	738300000	USD
CY2019	us-gaap	Revenues Revenues	780600000	USD
CY2018	us-gaap	Revenues Revenues	773400000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	145200000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142300000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4400000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6700000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6500000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	6500000	USD
CY2019Q3	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	5500000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-10200000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2700000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-3800000	USD
CY2020	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-1500000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	-2400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	100000	USD

Files In Submission

Name	View Source	Status
0001681622-20-000116-index-headers.html	Edgar Link	pending
0001681622-20-000116-index.html	Edgar Link	pending
0001681622-20-000116.txt	Edgar Link	pending
0001681622-20-000116-xbrl.zip	Edgar Link	pending
exhibit1018-10xk2020.htm	Edgar Link	pending
exhibit1025-10xk2020.htm	Edgar Link	pending
exhibit211-10xk2020.htm	Edgar Link	pending
exhibit231-10xk2020.htm	Edgar Link	pending
exhibit311-10xk2020.htm	Edgar Link	pending
exhibit312-10xk2020.htm	Edgar Link	pending
exhibit321-10xk2020.htm	Edgar Link	pending
exhibit322-10xk2020.htm	Edgar Link	pending
exhibit41-10xk2020.htm	Edgar Link	pending
exhibit43-10xk2020.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrex-20201002.htm	Edgar Link	pending
vrex-20201002.xsd	Edgar Link	pending
vrex-20201002_cal.xml	Edgar Link	unprocessable
vrex-20201002_def.xml	Edgar Link	unprocessable
vrex-20201002_g1.jpg	Edgar Link	pending
vrex-20201002_g2.jpg	Edgar Link	pending
vrex-20201002_htm.xml	Edgar Link	completed
vrex-20201002_lab.xml	Edgar Link	unprocessable
vrex-20201002_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VREX
Varex Imaging Corp Stock $vrex

2020 Q4 Form 10-K Financial Statement

#000168162220000116 Filed on November 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VREX Varex Imaging Corp Stock $vrex

2020 Q4 Form 10-K Financial Statement

#000168162220000116 Filed on November 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VREX
Varex Imaging Corp Stock $vrex